208 related articles for article (PubMed ID: 26836515)
1. Dissociable Effects of Dopamine on the Initial Capture and the Reactive Inhibition of Impulsive Actions in Parkinson's Disease.
van Wouwe NC; Kanoff KE; Claassen DO; Spears CA; Neimat J; van den Wildenberg WP; Wylie SA
J Cogn Neurosci; 2016 May; 28(5):710-23. PubMed ID: 26836515
[TBL] [Abstract][Full Text] [Related]
2. Dopamine agonists and the suppression of impulsive motor actions in Parkinson disease.
Wylie SA; Claassen DO; Huizenga HM; Schewel KD; Ridderinkhof KR; Bashore TR; van den Wildenberg WP
J Cogn Neurosci; 2012 Aug; 24(8):1709-24. PubMed ID: 22571461
[TBL] [Abstract][Full Text] [Related]
3. Dopa therapy and action impulsivity: subthreshold error activation and suppression in Parkinson's disease.
Fluchère F; Deveaux M; Burle B; Vidal F; van den Wildenberg WP; Witjas T; Eusebio A; Azulay JP; Hasbroucq T
Psychopharmacology (Berl); 2015 May; 232(10):1735-46. PubMed ID: 25510855
[TBL] [Abstract][Full Text] [Related]
4. Taq1A polymorphism and medication effects on inhibitory action control in Parkinson disease.
McDonell KE; van Wouwe NC; Harrison MB; Wylie SA; Claassen DO
Brain Behav; 2018 Jul; 8(7):e01008. PubMed ID: 29856137
[TBL] [Abstract][Full Text] [Related]
5. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
[TBL] [Abstract][Full Text] [Related]
6. Dopamine-agonists and impulsivity in Parkinson's disease: impulsive choices vs. impulsive actions.
Antonelli F; Ko JH; Miyasaki J; Lang AE; Houle S; Valzania F; Ray NJ; Strafella AP
Hum Brain Mapp; 2014 Jun; 35(6):2499-506. PubMed ID: 24038587
[TBL] [Abstract][Full Text] [Related]
7. Motivational Sensitivities Linked to Impulsive Motor Errors in Parkinson's Disease.
Laurent R; van Wouwe NC; Turchan M; Tolleson C; Phibbs F; Bradley E; van den Wildenberg W; Wylie SA
J Int Neuropsychol Soc; 2018 Feb; 24(2):128-138. PubMed ID: 28828997
[TBL] [Abstract][Full Text] [Related]
8. Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's disease.
Trujillo P; van Wouwe NC; Lin YC; Stark AJ; Petersen KJ; Kang H; Zald DH; Donahue MJ; Claassen DO
Cortex; 2019 Jun; 115():99-111. PubMed ID: 30776736
[TBL] [Abstract][Full Text] [Related]
9. Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory.
Costa A; Peppe A; Dell'Agnello G; Caltagirone C; Carlesimo GA
Neuropsychologia; 2009 Apr; 47(5):1374-81. PubMed ID: 19428401
[TBL] [Abstract][Full Text] [Related]
10. Perceptual decision-making in patients with Parkinson's disease.
Djamshidian A; O'Sullivan SS; Lawrence AD; Foltynie T; Aviles-Olmos I; Magdalinou N; Tomassini A; Warner TT; Lees AJ; Averbeck BB
J Psychopharmacol; 2014 Dec; 28(12):1149-54. PubMed ID: 25237123
[TBL] [Abstract][Full Text] [Related]
11. Action naming in Parkinson's disease patients on/off dopamine.
Herrera E; Cuetos F
Neurosci Lett; 2012 Apr; 513(2):219-22. PubMed ID: 22387157
[TBL] [Abstract][Full Text] [Related]
12. Subthalamic deep brain stimulation restores automatic response activation and increases susceptibility to impulsive behavior in patients with Parkinson's disease.
Plessow F; Fischer R; Volkmann J; Schubert T
Brain Cogn; 2014 Jun; 87():16-21. PubMed ID: 24632184
[TBL] [Abstract][Full Text] [Related]
13. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
[TBL] [Abstract][Full Text] [Related]
15. The effect of dopaminergic medication on conflict adaptation in Parkinson's disease.
Ruitenberg MFL; Abrahamse EL; Santens P; Notebaert W
J Neuropsychol; 2019 Mar; 13(1):121-135. PubMed ID: 28714199
[TBL] [Abstract][Full Text] [Related]
16. Verbal fluency in Parkinson's disease patients on/off dopamine medication.
Herrera E; Cuetos F; Ribacoba R
Neuropsychologia; 2012 Dec; 50(14):3636-40. PubMed ID: 22995942
[TBL] [Abstract][Full Text] [Related]
17. Mesocorticolimbic hemodynamic response in Parkinson's disease patients with compulsive behaviors.
Claassen DO; Stark AJ; Spears CA; Petersen KJ; van Wouwe NC; Kessler RM; Zald DH; Donahue MJ
Mov Disord; 2017 Nov; 32(11):1574-1583. PubMed ID: 28627133
[TBL] [Abstract][Full Text] [Related]
18. Subthalamic nucleus stimulation influences expression and suppression of impulsive behaviour in Parkinson's disease.
Wylie SA; Ridderinkhof KR; Elias WJ; Frysinger RC; Bashore TR; Downs KE; van Wouwe NC; van den Wildenberg WP
Brain; 2010 Dec; 133(Pt 12):3611-24. PubMed ID: 20861152
[TBL] [Abstract][Full Text] [Related]
19. Impulsive and Compulsive Behaviors in Parkinson's Disease: The Norwegian ParkWest Study.
Erga AH; Alves G; Larsen JP; Tysnes OB; Pedersen KF
J Parkinsons Dis; 2017; 7(1):183-191. PubMed ID: 27911342
[TBL] [Abstract][Full Text] [Related]
20. Effects of pallidal deep brain stimulation and levodopa treatment on reaction-time performance in Parkinson's disease.
Schubert T; Volkmann J; Müller U; Sturm V; Voges J; Freund HJ; Von Cramon DY
Exp Brain Res; 2002 May; 144(1):8-16. PubMed ID: 11976755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
